Blog
Dr. Khoruts shares the stool donor process at the University of Minnesota’s Microbiota Therapeutic Program and the effectiveness of Intestinal Microbiota Transplants in treating c. difficile infections.
For the U of M’s Microbiota Therapeutics Program team, this work is personal. Amanda Kabage’s life saving Intestinal Microbiota Transplant not only gave her health back, but a new career focus.
Achieving Cures Together is honored to be highlighted with Dr. Khoruts and the University of Minnesota’s Microbiota Therapeutics Program for our development of encapsulated microbiota.
The adjusted terminology – intestinal microbiota transplant – merely shifts the focus from the donor to the recipient. The patients are getting an intestinal microbiota transplant because their own intestinal microbiota requires repair. We’re certainly not trying to fix someone’s feces.
Healthy donor feces is a life-saving therapy, and the treatment provides huge cost savings — fecal microbiota transplantation (FMT) saves at least $1.2 million each time 50 patients are treated for Clostridioides difficile at a public hospital. These are the perspectives of the first observational study in the world to detail the process for the 50 patients who received FMY for Clostridioides difficile colitis in 2014 and 2015 as an alternative to antibiotics.
Transforming the microbial environment in the guts of children diagnosed with autism could significantly ease the severity of their condition’s signature traits, according to newly published research.
Newsletter Signup
